News

Unlocking the Mysteries of Pancreatic Cancer
Wednesday, October 23, 2013

Unlocking the Mysteries of Pancreatic Cancer

Learning that you have pancreatic cancer is terrible news. It is the fourth leading cause of cancer-related deaths in the United States, and, for reasons unknown, African-Americans have a 40 to 50 percent increased risk of contracting this cancer. Surgery to remove the tumor remains the first line of defense, but the outlook for survival in patients is still bleak. Chemotherapeutic drugs have had minimal effect on improving patient survival.

Read more >

Recruiting is often critical to building a winning team in sports, and it is the same in research. While attracting the best athletes usually costs professional sports teams millions, the recruitment of three top scientists by the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center is actually bringing $7.7 million in new research funding to the campus and potentially millions more to the state’s economy.

Read more >

Scientists at the Oklahoma Medical Research Foundation have developed an experimental treatment for glioblastoma, a deadly form of brain cancer. Beginning this month, the Stephenson Cancer Center at the University of Oklahoma will be conducting a clinical trial to test the novel therapy in eligible patients who suffer from the disease.

Read more >

The Stephenson Cancer Center at the University of Oklahoma is pleased to announce the recruitment of Takemi Tanaka, Ph.D. Tanaka’s work focuses on the development of new and personalized therapeutic approaches for the prevention and treatment breast and other cancers. She will be appointed an Oklahoma TSET Cancer Research Scholar in recognition of the Oklahoma Tobacco Settlement Endowment Trust’s efforts to reduce the burden of cancer in the state by supporting innovative research.

Read more >
Nano-Medicine Researcher Joins Stephenson Cancer Center

Priyabrata Mukherjee, PhD, a researcher whose work focuses on nanotechnology applications in cancer drug development, has joined the Stephenson Cancer Center. Mukherjee will collaborate with biomedical researchers at the University of Oklahoma Health Sciences Center and nanotechnology investigators at OU Norman to develop nano-based applications for cancer drug development and delivery.

Read more >
1234